Showing results (1731-1740 of 1,774) with videos related to
Sort By:
Pageof 178
JCI Insight|September 21, 2018
Haptoglobin improves shock, lung injury, and survival in canine pneumoniaKenneth E Remy, Irene Cortés-Puch, Steven B Solomon, et al.Biorxiv : the Preprint Server for Biology|June 21, 2024
Cardiac Magnetic Resonance Studies in a Large Animal Model that Simulates the Cardiac Abnormalities of Human Septic ShockVerity J Ford, Willard N Applefeld, Jeffrey Wang, et al.Genetics and Molecular Research : GMR|October 6, 2016
Influence of CYP2C19 on Helicobacter pylori eradication in Brazilian patients with functional dyspepsiaD D Nabinger, L E Mazzoleni, G B Sander, et al.Human Molecular Genetics|December 1, 1996
Homozygous and compound heterozygous mutations at the Werner syndrome locusJ Oshima, C E Yu, C Piussan, et al.Transplantation and Cellular Therapy|September 27, 2021
Real-Time Reflectance Confocal Microscopy of Cutaneous Graft-versus-Host Disease Correlates with HistopathologyRachel E Reingold, Jilliana Monnier, Marco Ardigò, et al.The Lancet. Neurology|February 5, 2008
Clinical and angiographic risk factors for stroke and death within 30 days after carotid endarterectomy and stent-protected angioplasty: a subanalysis of the SPACE studyRobert Stingele, Jürgen Berger, Karsten Alfke, et al.Biorxiv : the Preprint Server for Biology|August 1, 2025
Myocyte Damage and Mass Loss Drives Increasing Water Content, Compliance, and Survival in Septic CardiomyopathyVerity J Ford, Steven B Solomon, Junfeng Sun, et al.Global Change Biology|August 14, 2021
Integrating environmental variability to broaden the research on coral responses to future ocean conditionsMaren Ziegler, Andrea Anton, Shannon G Klein, et al.Cancer Research|November 1, 1981
Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by clinical, virological, and immunopathological studiesD T Purtilo, K Sakamoto, A K Saemundsen, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 8, 2014
Everolimus and early calcineurin inhibitor withdrawal: 3-year results from a randomized trial in liver transplantationM Sterneck, G M Kaiser, N Heyne, et al.Pageof 178